Raloxifene is an estrogen agonist and antagonist, meaning it activates or deactivates certain estrogen receptors based on their location in the body. Also known as a selective estrogen receptor modulator (SERM).
Agonizes estrogen receptors in the bone, causing a reduction in the normal breakdown of bone that happens during bone turnover. By decreasing the breakdown of bone, it increases bone mineral density.
Helps to prevent invasive breast cancer because it blocks the actions of estrogen in certain breast tissue that may become cancerous when exposed to high levels of estrogen over time.
Showing the single result
-
$110
End of content
End of content
